Drug Type Small molecule drug |
Synonyms |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors), COX-2 inhibitors(Cyclooxygenase-2 inhibitors), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H26ClNO2 |
InChIKeyPPKXEPBICJTCRU-XMZRARIVSA-N |
CAS Registry36282-47-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis | Phase 1 | US | 30 Jan 2022 |